Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

BACKGROUND: Many people who inject drugs in the United States have chronic hepatitis C virus (HCV). On-site treatment in opiate agonist treatment (OAT) programs addresses HCV treatment barriers, but few evidence-based models exist. METHODS: We evaluated the cost-effectiveness of HCV treatment models...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Gutkind, Sarah, Schackman, Bruce R, Morgan, Jake R, Leff, Jared A, Agyemang, Linda, Murphy, Sean M, Akiyama, Matthew J, Norton, Brianna L, Litwin, Alain H, Linas, Benjamin P
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318779/
https://ncbi.nlm.nih.gov/pubmed/31095683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz384
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados